LABORATORY EVALUATION OF ANTISCHISTOSOMAL AGENTS*
1969; Wiley; Volume: 160; Issue: 2 Linguagem: Inglês
10.1111/j.1749-6632.1969.tb15867.x
ISSN1749-6632
Autores Tópico(s)Plant Pathogens and Resistance
ResumoAnnals of the New York Academy of SciencesVolume 160, Issue 2 p. 429-460 LABORATORY EVALUATION OF ANTISCHISTOSOMAL AGENTS* J. Pellegrino, J. Pellegrino Institute de Biologia, Faculdade de Filosojia Universidade Federal de Minus Gerais and Insiiiuto National de Endemias Rurais Centra de Pesquisas René Rachou Belo Horizonte, BrasilSearch for more papers by this authorNaftale Katz, Naftale Katz Institute de Biologia, Faculdade de Filosojia Universidade Federal de Minus Gerais and Insiiiuto National de Endemias Rurais Centra de Pesquisas René Rachou Belo Horizonte, BrasilSearch for more papers by this author J. Pellegrino, J. Pellegrino Institute de Biologia, Faculdade de Filosojia Universidade Federal de Minus Gerais and Insiiiuto National de Endemias Rurais Centra de Pesquisas René Rachou Belo Horizonte, BrasilSearch for more papers by this authorNaftale Katz, Naftale Katz Institute de Biologia, Faculdade de Filosojia Universidade Federal de Minus Gerais and Insiiiuto National de Endemias Rurais Centra de Pesquisas René Rachou Belo Horizonte, BrasilSearch for more papers by this author First published: October 1969 https://doi.org/10.1111/j.1749-6632.1969.tb15867.xCitations: 21 * The work reported in this paper was supported, in part, by research grants from the United States Public Health Service (No. AI-05917-04), National Institutes of Health, Bethesda, Md.; the United States Department of the Army (No. DA-HC19-67-G-0033); and the World Health Organization, Geneva, Switzerland. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References AZIM, M. A. & S. G. COWPER. 1950. On the maintenance of strains of Schistosoma mansoni, S. haematobium and S. matthei in the laboratory in Egypt, with special reference to the use of gerbils. Brit. J. Exp. Path. 31: 577– 589. BANG, F. B. & N. G. HAIRSTON. 1946. Studies on schistosomiasis japonica. IV. Chemotherapy of experimental schistosomiasis japonica. Amer. J. Hyg. 44: 348– 366. BARKER, L. R., E. BUEDING & A. R. TIMMS. 1966. The possible role of acetylcholine in Schistosoma mansoni. Brit. J. Pharmacol. Chemother. 26: 656– 665. BELL, D. R. 1963. A new method for counting Schistosoma mansoni eggs in faeces with special reference to therapeutic trials. Bull. WHO 29: 525– 530. BERBERIAN, D. A., E. W. DENNIS & H. W. FREELE. 1953. Chemotherapy of experimental Schistosoma mansoni infection in Swiss mice. C. R. V Congr. Int. Med. Trop. Palud. 2: 292– 305. BERBERIAN, D. A. & H. FREELE. 1964. Chemotherapeutic effect of antischistosomal drugs in experimentally induced Schistosoma mansoni infections in Swiss mice and Syrian hamsters. J. Parasit. 50: 435– 440. BERBERIAN, D. A., H. FREELE, D. Rosi, E. W. DENNIS & S. ARCHER. 1967. Schistosomicidal activity of Lucanthone hydrochloride, Hycanthone and their metabolites in mice and hamsters. J. Parasit. 53: 306– 311. BRENER, Z. 1957. Observaçõces sôbre a ação da Fuadina e do Miracil D em camundongos experimentalmente infectados com Schistosoma mansoni. Rev. Brasil Malar. Doenças Trop. 9: 489– 496. BRENER, Z. 1960. Chemotherapy of experimental schistosomiasis. III. Comparative drug activity of some antimonial compounds in mice experimentally infected with Schistosoma mansoni. Rev. Inst. Med. Trop. São Paulo 2: 224– 229. BRENER, Z. 1962. Contribuição ao estudo da terapêutica experimental da esquistossomose mansoni. Thesis. Belo Horizonte, Brasil. BRENER, Z. 1965. Chemotherapy of experimental schistosomiasis. V. Studies of some techniques used for the assessment of drug activity.. Rev. Inst. Med. Trop. São Paulo 6: 167– 170. BRENER, Z. & R. J. ALVARENGA. 1962. Susceptibilidade do Cebus apella macrocephalus Spix, 1823 a infecçães experimentais pelo Schistosoma mansoni. Rev. Inst. Med. Trop. São Paulo 4: 180– 186. BRENER, Z. & E. CHIARI. 1957. Ação da Fuadina e do Miracil D sôbre os estádios iniciais de desenvolvimento do Schistosoma mansoni no camundongo. Rev. Brasil. Malar. Doenças Trop. 9: 485– 488. BRENER, Z., J. PELLEGRINO & F. C. OLIVEIRA. 1956. Terepêutica experimental da esquitossomose mansoni. Aplicação do método de isolamento de granulomas do figado de camundongos. Rev. Brasil. Malar. Doenças Trop. 8: 583– 587. BRUCE, J. I. & E. H. SADUN. 1963. The suppressive activity of sodium antimony dimercaptosuccinate (TWSb) in experimental infections with Schistosoma mansoni. Amer. J. Trop. Med. Hyg. 12: 184– 187. BRUCE, J. I. & E. H. SADUN. 1966. Prophylactic and curative activities of antimony (III) dimercapto succinic acid in olive oil suspension, dicarbonic acid hydrazide, an organic phosphorus compound (Ronnel) and a nitro-thiazole derivative in rhesus monkeys experimentally infected with Schistosoma mansoni. Amer. J. Trop. Med. Hyg. 15: 324– 332. BRUCE, J. I., E. H. SADUN & M. J. SCHOENBECHLER. 1962. The prophylactic and curative activity of sodium antimony dimercaptosuccinate (TWSb) in experimental infections with Schistosoma mansoni. Amer. J. Trop. Med. Hyg. 11: 25– 30. BUEDING, E. 1949. Metabolism of parasitic helminths. Physiol. Rev. 29: 195– 218. BUEDING, E. 1950. Carbohydrate metabolism of Schistosoma mansoni. J. Gen. Physiol. 33: 475– 495. BUEDING, E. 1952. Acetylcholinesterase activity of Schistosoma mansoni. Brit. J. Pharmacol. Chemother. 7: 563– 566. BUEDING, E. 1959. Mechanisms of action of schistosomicidal agents. J. Pharm. Pharmacol. 11: 385– 392. BUEDING, E. & S. KOLETSKY. 1950. Content and distribution of glycogen in Schistosoma mansoni. Proc. Soc. Exp. Biol. Med. 73: 594– 596. BUEDING, E. & J. A. McKiNNON. 1955. Hexokinases of Schistosoma mansoni. J. Biol. Chem. 215: 495– 506. BUEDING, E. & J. M. MANSOUR. 1957. The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansomi. Brit. J. Pharmacol. Chemother. 12: 159– 165. BUEDING, E. & N. PENEDO. 1957. Effects of alkyldibenzylamines on Schistosoma mansoni. Fed. Proc. 16: 286. BUEDING, E. & L. PETERS. 1951. Effect of naphtoquinones on Schistosoma mansoni in vitro and in vivo. J. Pharmacol. Exp. Ther. 101: 210– 229. BUEDING, E., L. PETERS, S. KOLETSKY & D. V. MOORE. 1953. Effect of respiratory inhibition on Schistosoma mansoni. Brit. J. Pharmacol. Chemother. 8: 15– 18. BUEDING, E., L. PETERS, J. F. WAITE. 1947. Effect of 2-methyl-l, 4-napthoquinone on glycolysis of Schislosoma mansoni. Proc. Soc. Exp. Biol. Med. 64: 111– 113. CAMPBELL, W. C. & A. C. CUCKLER. 1963. Efficacy of a 2-phenyl quinoline against experimental Schistosoma mansoni infections in mice and monkeys. J. Parasit. 49: 528. CANCADO, J. R., A. S. CUNHA, D. G. CARVALHO & J. N. S. CAMBRAIA. 1965. Evaluation of the treatment of human Schistosoma mansoni infection by the quantitative oogram technique. Bull. WHO 33: 557– 566. CHEEVER, A. W. & T. H. WELLER. 1958. Observations on the growth and nutritional requirements of Schistosoma mansoni in vitro. Amer. J. Hyg. 68: 322– 339. CIBA FILM UNIT. 1966. "Science against Schistosomiasis". J. Pellegrino, Director. (16 mm, color, 30 minutes). CLEGG, J. A. 1961. A continuous-flow apparatus for in vitro culture of Schistosoma man-soni. Bull. Res. Counc. Israel 9: 168– 170. CLEGG, J. A. 1965. In vitro cultivation of Schistosoma mansoni. Exp. Parasit. 16: 133– 147. COELHO, B. & A. MAGALHÃES FILHO. 1953. Resultados patologicos de infestação experimental de Schistosoma mansoni em macaco Cebus sp. Publ. Avulsas Inst. Aggeu Magalhães 2: 61– 97. COLLINS, R. F., M. DAVIS, N. D. EDGE, J. HILL, H. W. READING & E. R. TURNBULL. 1959. The schistosomicidal and toxic effects of some N-p-aminophenoxyalkylamides. Brit. J. Pharmacol. Chemother. 14: 467– 476. CUCKLER, A. C., A. B. KUPFERBERG & N. MILLMAN. 1955. Chemotherapeutic and tolerance studies on aminonitro-thiazoles. Antibiot. Chemother. 5: 540– 550. DE CARNERI, I. 1958. Osservazioni sugli indici dell'azione chemioterapica di sostanze attive su Schistosoma mansoni nel topo. Arch. Hal. Sci. Med. Trop. 39: 400– 424. DE MEILLON, B., E. C. ENGLAND & G. LÄMMLER. 1956. Experimental bilharziasis in animals. IV. Chemoprophylaxis in bilharziasis. S. Afr. Med. J. 30: 611– 613. DICKERSON, G.1965a, Observations on "lung-shift" after chemotherapy in mice infected with Schistosoma mansoni. Bull WHO 33: 509– 515. DICKERSON, G.1965b. Effect of anaesthetics on mature infections of Schistosoma mansoni in the white mouse. Nature 206: 953– 954. ELSLAGER, E. F., F. W. SHORT, D. F. WORTH, J. E. MEISENHELDER, H. NAJARIAN & P. E. THOMPSON. 1961. Effects of tris (p-aminophenyl)-carbonium salts and related compounds on experimental schistosomiasis and paragonimiasis. Nature 190: 628– 629. FAIGLE, J. W. & H. KEBERLE. 1966. The metabolic fate of CIBA 32644-Ba. Acta Trop. Suppl. 9: 8– 22. FARIA, J. & J. PELLEGRINO. 1963. Observações sôbre a infecçαo experimental do hamster (Cricetus auratus) pelo Schistosoma mansoni. Rev. Inst. Med. Trop. Sao Paulo 5: 281– 286. GEAKE, C. R. 1962. "Lung-shift" in mice infected with Schistosoma mansoni following chemotherapy. Amer. J. Trop. Med. Hyg. 11: 477– 480. GONNERT, R. 1955. Schistosomiasis Studien. II. Über die Eibildung bei Schistosoma mansoni und das Schiksal der Eier in Wirtsorganismus. Z. Tropenmed. Parasit. 6: 33– 52. GÖNNERT, R. & H. VOGEL. 1955. Über die Abhängigkeit des Therapieerfolges von Wirts-und Parasitenstamm bei der experimentellen Schistosomiasis. Z. Tropenmed. Parasit. 6: 193– 198. HALAWANI, A., A. HAFEZ, J. NEWSOME & S. G. COWPER. 1949. Miracil D: effect on B. mansoni in vitro and in the treatment of urinary Bilharziasis. J. Roy. Egypt. Med. Ass. 32: 29– 51. HESS, R., J. W. FAIGLE & C. LAMBERT. 1966. Selective uptake on an antibilharzial nitro-thiazole compound by Schistosoma mansoni. Nature 210: 964– 965. HEWITT, R. & E. GILL. 1960. The "lung shift" of Schistosoma mansoni in mice following therapy with tartar emetic or Miracil D. Amer. J. Trop. Med. Hyg. 9: 402– 409. HEWITT, R. & E. GILL. 1962. Relationships between the age of the infections and the lung shift of mature Schistosoma mansoni in mice following therapy with tartar emetic. Amer. J. Trop. Med. Hyg. 11: 613– 619. HILL, J. 1956. Chemotherapeutic studies with laboratory infections of Schistosoma mansoni. Ann. Trop. Med. Parasit. 50: 39– 48. HILL, J., M. A. RUST, J. PELLEGRINO & J. FARIA. 1966. Use of the oogram to reveal the effect of a nitrofurylacrylamide on the eggs of Schistosoma mansoni. J. Parasit. 52: 822. HSÜ, S. Y., K. Y. CHU & H. F. HÜ. 1963. Drug susceptibility of geographic strains of Schistosoma japonicum. Z. Tropenmed. Parasit. 14: 37– 40. KAGAN, I. G. & C. LEE. 1952. Chemotherapy of experimental infections of mice with Schistosomatium douthitti, Schistosoma mansoni and Schistosoma japonicum. 3. Infect. Dis. 91: 224– 230. KATZ, N., D. BITTENCOURT, C. A. OLIVEIRA, R. P. DIAS, H. FERREIRA, E. GRINBAUM, C. B. DIAS & J. PELLEGRINO. 1966a. Clinical trials with CIBA 32, 644-Ba (Ambil-har®) in schistosomiasis mansoni. Folha Med. 53: 561– 567. KATZ, N., F. A. X. CANCADO & J. PELLEGRINO. 1967a. Ensaios chnicos na esqui-stossomose mansoni com Ambilhar® associado a barbitúricos. I. Efeitos colaterais. Folha Med. 54: 795– 804. KATZ, N. &J. PELLEGRINO. 1967. Unpublished data. KATZ, N., J. PELLEGRINO, M. T. FERREIRA, C. A. OLIVEIRA & C. B. DIAS. 1967b. Preliminary clinical trials with Hycanthone, a new antischistosomal agent. In press. KATZ, N., J. PELLEGRINO & J. M. P. MEMORIA. 1966b. Quantitative oogram method in Cebus monkeys experimentally infected with Schistosoma mansoni. J. Parasit. 52: 917– 919. KATZ, N., J. PELLEGRINO, C. A. OLIVEIRA & A. S. CUNHA. 1967c. Experimental chemotherapy of schistosomiasis. II. Laboratory and clinical trials with A-16612, a piper-azine derivative.. J. Parasit. 53: 1229– 1232. KHAYYAL, M. T. 1965. Significance of worm shifts in experimental schistosomiasis mansoni, with emphasis on the action of anaesthetics. Nature 205: 1331– 1332. KIKUTH, W. & R. GÖNNERT. 1948. Experimental studies on the therapy of schistosomiasis. Ann. Trop. Med. Parasit. 42: 256– 267. KIKUTH, W. & R. GÖNNERT. 1949. Experimentelle Untersuchungen und Erfahrungen mit dem neuen Schistosomiasismittel Miracil. Z. Tropenmed. Parasit. 1: 234– 258. KIKUTH, W., R. GÖNNERT, & H. MAUSS. 1946. Miracil, ein neues Chemotherapeuticum gegen die Darmbilharziose. Naturwissenschaften 33: 253. LAMBERT, C. R. 1966. Nouveau traitement des schistosomiases et de l'amibiase, le CIBA 32644-Ba. Acta Trop. 23: 1– 80. LAMBERT, C. R. & P. STAUFFER. 1964. Chemotherapy of experimental Schistosoma mansoni infections with a nitrothiazole derivative, CIBA 32, 644-Ba. Ann. Trop. Med. Parasit. 58: 292– 303. LÄMMLER, G. 1958. Beiträge zur experimentellen Schistosomiasis. I. Mitteilung. Untersuchungen zur Chemoprophylaxe der Bilharziose. Z. Tropenmed. Parasit. 9: 294– 310. LEE, C. L. & R. LEWERT. 1956. The maintenance of Schistosoma mansoni in the laboratory. J. Infect. Dis. 99: 15– 20. LUTTERMOSER, G. W. 1954. Studies on the chemotherapy of experimental schistosomiasis. I. A method for detecting schistosomacidal activity based on response of Schistosoma mansoni infections in mice to Fuadin therapy. J. Parasit. 40: 130– 137. LUTTERMOSER, G. W., J. I. BRUCE & D. B. MCMULLEN. 1960. The prophylactic and curative activity of l-maleinyl-4-(3′-chloro-4′-methyl-phenyl)-piperazine (Hoechst S-688) in experimental schistosome infections. Amer. J. Trop. Med. Hyg. 9: 39– 45. MANSOUR, T. E. & E. BUEDING. 1954. The actions of antimonials on glycolytic enzymes of Schistosoma mansoni. Brit. J. Pharmacol. Chemother. 9: 459– 462. MAO, S. P. & K. L. LYU. 1957. Studies on cultivation of Schistosoma japonicum. Med. Parazit. (Moskva) 26: 166– 172. MEISENHELDER, J. E. & P. E. THOMPSON. 1963. Comparative observations on Schistosoma mansoni infections in African green and rhesus monkeys. J. Parasit. 49: 567– 570. MOORE, D. V. & J. H. SANDGROUND. 1956. The relative egg producing capacity of Schistosoma mansoni and Schistosoma japonicum. Amer. J. Trop. Med. Hyg. 5: 831– 840. MOORE, D. V., T. K. YOLLES, H. E. MELENEY. 1949. A comparison of common laboratory animals as experimental hosts for Schistosoma mansoni. J. Parasit. 35: 156– 170. NEWSOME, J. 1953. Experiments with some Miracil, acridine, and diamidine compounds on Schistosoma mansoni infections in baboons. Trans. Roy. Soc. Trop. Med. Hyg. 47: 428– 430. NEWSOME, J. 1963. Observations on corticosteroid treatment of schistosomiasis in hamsters and baboons. Trans. Roy. Soc. Trop. Med. Hyg. 57: 425– 432. NEWSOME, J. & D. L. H. ROBINSON. 1954. Investigation of methods of maintaining Schistosoma mansoni in vitro. Ann. Trop. Med. Parasit. 48: 194– 200. NEWSOME, J. & D. L. H. ROBINSON. 1960. Preliminary observations on metabolites of Lucanthone. Trans. Roy. Soc. Trop. Med. Hyg. 54: 582– 584. OESTERLIN, M. 1934. Zur Chemotherapie der experimentellen Schistosomiasis. Arch. Schiffs-Tropenhyg. 38: 433– 441. OKPALA, I. 1959. A new method of testing drugs in experimental schistosomiasis mansoni in golden hamsters (Cricetus auratus). W. Afr. Med. J. 8: 94– 101. OLIVIER, L. & M. A. STIREWALT. 1952. An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J. Parasit. 38: 19– 23. PELLEGRINO, J. & Z. BRENER. 1956. Method for isolating schistosome granulomas from mouse liver. J. Parasit. 42: 564. PELLEGRINO, J., M. DE MARIA & J. FARIA. 1965a. Infection of the golden hamster with Schistosoma mansoni cercariae through the cheek pouch. J. Parasit. 51: 1015. PELLEGRINO, J. & J. FARIA. 1964. Early effect of tris (p-aminophenyl) carbonium pamoate on the egg laying of Schistosoma mansoni. J. Parasit. 50: 587. PELLEGRINO, J. & J. FARIA. 1965. The oogram method for the screening of drugs in schistosomiasis mansomi. Amer. J. Trop. Med. Hyg. 14: 363– 369. PELLEGRINO, J. & N. KATZ. 1967a. Cercarial slide flocculation and circumoval precipitin tests on Cebus monkeys experimentally infected with Schistosoma mansoni. J. Parasit. 53: 216– 217. PELLEGRINO, J. & N. KATZ. 1967b. Unpublished data. PELLEGRINO, J., N. KATZ, C. A. OLIVEIRA & K. OKABE. 1965b. Rectal biopsy and mucosal curettage in Cebus monkeys experimentally infected with Schistosoma mansoni and Schistosoma japonicum. J. Parasit. 51: 617– 621. PELLEGRINO, J., N. KATZ & A. RAICK. 1966. Therapeutical activity of CIBA 32, 644-Ba, a new nitro-thiazole derivative, on mice, hamsters and Cebus monkeys experimentally infected with Schistosoma mansomi. Folha Med. 52: 333– 342. PELLEGRINO, J., N. KATZ & J. F. SCHERRER. 1967a. Oogram studies with hycanthone, a new antischistosomal agent. J. Parasit. 53: 55– 59. PELLEGRINO, J., N. KATZ & J. F. SCHERRER. 1967b. Experimental chemotherapy of schistosomiasis. I. Laboratory trials with RD 12,869, a new aminoquinoline.. J. Parasit. 53: 1225– 1228. PELLEGRINO, J., C. A. OLIVEIRA & J. FARIA. 1963. The oogram in the study of relapse in experimental chemotherapy of schistosomiasis mansoni. J. Parasit. 49: 365– 370. PELLEGRINO, J., C. A. OLIVEIRA, J. FARIA & A. S. CUNHA. 1962. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Amer. J. Trop. Med. Hyg. 11: 201– 215. PELLEGRINO, J. & A. F. SIQUEIRA. 1956. Técnica de perfusão para colheita de Schistosoma mansoni em cobaias experimentalmente infestadas. Rev. Brasil Malar. Doenças Trop. 8: 589– 597. PRATA, A. 1957. Biópsia retal na esquistossomose mansoni. Bases e aplicações no diagnóstico e tratamento. 197 pp. Service Nacional de Educação Sanitária. Rio de Janeiro, Brasil . RADKE, M. G., L. A. BERRIOS-DURAN & K. MORAN. 1961. A perfusion procedure (Perf-O-Suction) for recovery of schistosome worms. J. Parasit. 47: 366– 368. RAISON, C. G. & O. D. STANDEN. 1955. The schistosomicidal activity of symmetrical diaminodiphenoxyalkanes. Brit. J. Pharmacol. Chemother. 10: 191– 199. ROBINSON, D. L. H. 1956. A routine method for the maintenance of Schistosoma mansoni in vitro. J. Helminth. 29: 193– 202. ROBINSON, D. L. H. 1960. Egg-laying by Schistosoma mansoni in vitro. Ann. Trop. Med. Parasit. 54: 112– 117. ROSI, D., G. PERUZZOTTI, E. W. DENNIS, D. A. BERBERIAN, H. FREELE & S. ARCHER. 1965. A new, active metabolite of Miracil D. Nature 208: 1005– 1006. Ross, O. A. & E. BUEDING. 1950. Survival of Schistosoma mansoni in vitro. Proc. Soc. Exp. Biol. Med. 73: 179– 182. SADUN, E. H., J. I. BRUCE, J. W. MOOSE & D. B. MCMULLEN. 1966a. The prophylactic and curative activity of a nitrothiazole derivative, l-(5-nitro-2-thiazolyl)-2-imidazolidinone, in rhesus monkeys experimentally infected with Schistosoma mansoni and mice infected with S. japonicum. Acta Trop. Suppl. 9: 69– 77. SADUN, E. H., F. LICHTENBERG & J. I. BRUCE. 1966b. Susceptibility and comparative pathology of ten species of primates exposed to infection with Schistosoma mansoni. Amer. J. Trop. Med. Hyg. 15: 705– 718. SCHUBERT, M.1948a. Conditions for drug testing in experimental schistosomiasis mansoni in mice. Amer. J. Trop. Med. 28: 121– 136. SCHUBERT, M.1948b. Screening of drugs in experimental schistosomiasis mansoni in mice. Amer. J. Trop. Med. 28: 137– 156. SCHUBERT, M.1948c. Effect of drugs during earliest stages of experimental schistosomiasis mansoni in mice. Amer. J. Trop. Med. 28: 157– 162. SCHUBERT, M., E. GOLDBERG & F. G. SCHREIBER. 1949. Comparison of several antimonials in the treatment of experimental schistosomiasis in mice. Amer. J. Trop. Med. 29: 115– 127. SCHWINK, T. M. 1955. Use of organ egg counts in assaying chemotherapeutic activity against Schistosoma mansoni. J. Parasit. 41(sect. 2): 26. SENFT, A. W. 1958. A perfusion apparatus for maintenance and observation of schisto-somes in vitro. J. Parasit. 44: 652– 658. SENFT, A. W. 1965. Recent developments in the understanding of amino acid and protein metabolism by Schistosoma mansoni in vitro. Ann. Trop. Med. Parasit. 59: 164– 168. SENFT, A. W. & D. G. SENFT. 1962. A chemically defined medium for maintenance of Schistosoma mansoni. J. Parasit. 48: 551– 554. STANDEN, O. D. 1949. Experimental schistosomiasis. II. Maintenance of Schistosoma mansoni in the laboratory, with some notes on experimental infection with S. haematobium. Ann. Trop. Med. Parasit. 43: 268– 283. STANDEN, O. D.1953a. Experimental schistosomiasis. III. Chemotherapy and mode of drug action. Ann. Trop. Med. Parasit. 47: 26– 43. STANDEN, O. D.1953b. The relationship of sex in Schistosoma mansoni to migration within the hepatic portal system of experimentally infected mice. Ann. Trop. Med. Parasit. 47: 139– 145. STANDEN, O. D.1955a. The progress of degenerative changes in schistosomes following the treatment of experimental infections with 1:7-bis (p-dimethylaminophenoxy)heptane. Trans. Roy. Soc. Trop. Med. Hyg. 49: 416– 423. STANDEN, O. D.1955b. The treatment of experimental schistosomiasis in mice: sexual maturity and drug response. Ann. Trop. Med. Parasit. 49: 183– 192. STANDEN, O. D. 1963. Chemotherapy of helminthic infections. In Experimental Chemotherapy. R. J. Schnitzer & F. Hawking, Eds. I: 741– 756. Academic Press Inc. New York , N. Y. STIREWALT, M. A. 1963. Seminar on immunity to parasitic helminths. IV. Schistosome infections. Exp. Parasit. 13: 18– 44. STIREWALT, M. A., R. E. KUNTZ & A. S. EVANS. 1951. The relative susceptibilities of the commonly-used laboratory mammals to infection by Schistosoma mansoni. Amer. J. Trop. Med. 31: 57– 82. STOHLER, H. R. & J. R. FREY. 1963. Chemotherapy of experimental schistosomiasis mansoni: prophylactic and protective activity of clinically active compounds in mice and hamsters. Ann. Trop. Med. Parasit. 57: 466– 480. STOHLER, H. R. & J. R. FREY. 1964. Chemotherapy of experimental schistosomiasis mansoni: prophylactic, protective and therapeutic activity of sodium antimony dimer-captosuccinate and antimony dimercaptosuccinic acid in mice and hamsters. Ann. Trop. Med. Parasit. 58: 280– 291. STOHLER, H., J. R. FREY, J. PELLEGRINO & J. FARIA. 1963. Toxicologic and chemo-therapeutic studies of different clinically active drugs in Schistosoma mansoni infection of mice and hamsters. Abstr. Seventh Int. Congr. Trop. Med. Malaria. : 38– 39. STRIEBEL, H. P. & F. KRADOLFER. 1966. Mode of action of CIBA 32644-Ba in experimental schistosomiasis. Acta Trop. Suppl. 9: 54– 58. THOMPSON, P. E., J. E. MEISENHELDER, A. K. MOORE & J. A. WAITZ. 1965. Laboratory studies on the joint effects of certain tris (paminophenyl) carbonium salts and anti-monials as antischistosomal drugs. Bull. WHO 33: 517– 535. THOMPSON, P. E., J. E. MEISENHELDER & H. NAJARIAN. 1962. Laboratory studies on the effects of tris (p-aminophenyl)-carbonium salts, tris (p-aminophenyl)methanol, and Lucanthone hydrochloride against Schistosoma mansoni. Amer. J. Trop. Med. Hyg. 11: 31– 45. TIMMS, A. R. & E. BUEDING. 1959. Studies of a proteolytic enzyme from Schistosoma mansoni. Brit. J. Pharmacol. Chemother. 14: 68– 73. VOGEL, H. & W. MINNINO. 1947. Ueber die Einwirkung von Brechweinstein, Fuadin und Emetin auf Bilharzia japonica und deren Eier im Kaninchenversuch. Acta Trop. 4: 97– 116. VOGEL, H. & W. MINNING. 1948. The action of Miracil in Schistosoma japonicum infections in laboratory animals. Ann. Trop. Med. Parasit. 42: 268– 270. WATSON, J. M., M. A. AZIM & A. HALAWANI. 1948. Investigations on the antibilharzial action of Miracil D (Nilodin). Trans. Roy. Soc. Trop. Med. Hyg. 42: 37– 54. WILHELM, M. & P. SCHMIDT. 1966. The chemistry of CIBA 32,644-Ba. Acta Trop. Suppl. 9: 3– 7. YOKOGAWA, M., H. YOSHIMURA & M. SANO. 1966. Experimental studies on the therapeutic effect of CIBA 32,644-Ba against Schistosoma japonicum in mice. Acta. Trop. Suppl. 9: 78– 88. YOLLES, T. K., D. V. MOORE, D. L. DEGIUSTI, C. A. RIPSON & H. E. MELENEY. 1947. A technique for the perfusion of laboratory animals for the recovery of schistosomes. J. Parasit. 33: 419– 426. Citing Literature Volume160, Issue2The Pharmacological and Chemotherapeutic Properties of Niridazole and Other Antischistomal CompoundsOctober 1969Pages 429-460 ReferencesRelatedInformation
Referência(s)